Agile Therapeutics
AGRX
#10921
Rank
S$13.36 M
Marketcap
S$1.94
Share price
0.00%
Change (1 day)
314.10%
Change (1 year)

Earnings for Agile Therapeutics (AGRX)

Earnings in 2024 (TTM): -S$20.23 Million

According to Agile Therapeutics 's latest financial reports the company's current earnings are S$21.56 Million. In 2023 the company made an earning of -S$16.73 Million a decrease over its 2022 earnings that were of -S$6.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agile Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$20.23 Million20.95%
2023 -S$16.73 Million172.57%
2022 -S$6.14 Million-93.26%
2021 -S$90.99 Million45.62%
2020 -S$62.49 Million161.98%
2019 -S$23.86 Million-2.78%
2018 -S$24.54 Million-27.47%
2017 -S$33.83 Million-10.16%
2016 -S$37.65 Million-14.2%
2015 -S$43.88 Million88.45%
2014 -S$23.29 Million41.72%
2013 -S$16.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.59 B-174,517.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$8.85 B-46,066.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.85 B-51,277.96%๐Ÿ‡บ๐Ÿ‡ธ USA
TherapeuticsMD
TXMD
S$0.15 M-100.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
S$84.45 M-538.45%๐Ÿ‡บ๐Ÿ‡ธ USA